Delcath Systems, Inc. ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced full year 2025 financial ...

In Europe, the device-only configuration of the HDS is regulated as a Class III medical device and is approved for sale under the trade name CHEMOSAT Hepatic Delivery System for Melphalan ...

Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson ... or bortezomib, melphalan, and prednisone for the transplant-ineligible group.

HealthDay News — For patients with unresectable metastatic uveal melanoma (mUM), the drug/device combination melphalan/hepatic delivery system (HDS) is efficacious and has a favorable risk-benefit ...

The product is supplied as a 90mg/mL multiple-dose vial for dilution. Ivra ™, a ready-to-dilute liquid formulation of melphalan, has been made available by Apotex. Ivra is an alkylating drug ...

WESTON, Fla., May 9, 2025 /CNW/ - Apotex Corp. today launched IVRA™ (Melphalan) hydrochloride injection 90mg/ml multidose vial ("IVRA"), first ready-to-dilute liquid formulation of Melphalan ...

The Central Board of Secondary Education (CBSE) has declared the Class 12th Board Results 2025, offering relief to over 14 lakh students in India and abroad. Results are available on official ...

The overall pass percentage is 88.39%. The CBSE conducted the Class 12 board examination from February 15 to April 4, 2025. The exam was conducted in single shifts from 10:30 AM to 1:30 PM on all ...